Results 101 to 110 of about 346,617 (305)

Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion

open access: yesLiver Transplantation, EarlyView., 2022
Abstract End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been specifically assessed.
Damiano Patrono   +8 more
wiley   +1 more source

Metal‐Free Halogen‐Engineered Carbon Nanotubes for Highly Efficient Oxygen Reduction Reaction

open access: yesENERGY &ENVIRONMENTAL MATERIALS, EarlyView.
In work employs density functional theory screening to guide the halogen engineering of metal‐free, Cl‐mediated carbon nanotubes for a highly efficient oxygen reduction reaction (ORR). Cl‐mediation optimally tunes the electronic structure and binding energies of oxygen intermediates, delivering an ORR activity rivaling that of commercial Pt/C, high 4e−
Kai Zhao   +11 more
wiley   +1 more source

How to predict neurogenic pulmonary edema in aneurysmal subarachnoid hemorrhage?: Neurogenic pulmonary edema in aneurysmal SAH [PDF]

open access: yesSerbian Journal of Anesthesia and Intensive Therapy, 2019
Introduction: Neurogenic pulmonary edema (NPE) is a clinical syndrome characterized by the acute onset of pulmonary edema after sudden raise of intracranial pressure.
Nastasović Tijana   +5 more
doaj  

Pediatric poisonings: analysis and clinical management. [PDF]

open access: yesPediatric Anesthesia and Critical Care Journal (PACCJ)
Pediatric poisonings represent a significant global health issue, with important implications for children’s well-be- ing and healthcare resources. Toxic agents include drugs, household products, plants and substances of abuse, with exposure occurring ...
M. Cirronis   +8 more
doaj   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray   +2 more
wiley   +1 more source

Practice characteristics of Emergency Department extracorporeal cardiopulmonary resuscitation (eCPR) programs in the United States: The current state of the art of Emergency Department extracorporeal membrane oxygenation (ED ECMO). [PDF]

open access: yes, 2016
PURPOSE: To characterize the current scope and practices of centers performing extracorporeal cardiopulmonary resuscitation (eCPR) on the undifferentiated patient with cardiac arrest in the emergency department.
Becker, Lance   +13 more
core   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié   +5 more
wiley   +1 more source

ICU Admission-Related Factors Affecting the Duration of Mechanical Ventilation After Elective Cardiac Surgery—Retrospective Cohort Study from a Tertiary Center in Croatia

open access: yesMedicina
Background and Objectives: Enhancing recovery after cardiac surgery involves minimally invasive procedures, early extubation/mobilization, and swift discharge. While mechanical ventilation is often essential post-operation, prolonged invasive ventilation
Darko Kristović   +11 more
doaj   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Cardiocerebral Resuscitation [PDF]

open access: yesCirculation, 2005
Received August 4, 2004; revision received November 24, 2004; accepted December 10, 2004. “Why is it that every time I press on his chest he opens his eyes, and every time I stop to breathe for him he goes back to sleep?” 1 This article reviews research that shows that cardiopulmonary resuscitation (CPR) as it has been practiced and as it is ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy